Manifestaciones cutáneas asociadas con el HTLV-1

-A A +A
Revisión de tema
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 67-73

Manifestaciones cutáneas asociadas con el HTLV-1

.
Autor(es): 
Claudia Juliana Díaz
clajudiaz@yahoo.com
Médica dermatóloga; docente, Escuela de Dermatología y Cirugía Dermatológica, Departamento de Medicina Interna, Universidad del Valle, Cali, Colombia
Miller Valencia
Médico, residente, Escuela de Dermatología y Cirugía Dermatológica, Departamento de Medicina Interna, Universidad del Valle, Cali, Colombia
Resumen: 

El HTLV-1 es un virus linfotrópico y neurotrópico endémico en varios países del mundo, considerado el agente etiológico de la paraparesia espástica tropical y mielopatía asociada a HTLV-1 y de la leucemia y linfoma de células T del adulto. Se acompaña de diversas manifestaciones clínicas cutáneas y sistémicas, como polimiositis, alveolitis pulmonar, uveítis, síndrome de Sjögren, artropatías, estrongiloidiasis, crioglobulinemia y gammapatías monoclonales, entre otras, que producen gran morbilidad en los infectados.

Palabras clave: 
virus linfotrópico T humano, dermatitis Infecciosa, paraparesia espástica tropical, leucemia/linfoma de células T del adulto.

Summary: 

The HTLV-1 is a neurotropic and lymphotropic virus endemic in several countries, considered the etiological agent of tropical spastic paraparesis/HTLV-1 associated myelopathy (PET/MAH) and the adult T-cell leukemia/lymphoma (ATL). It is associated with various cutaneous and systemic manifestations such as polymyositis, pulmonary alveolitis, uveitis, Sjögren syndrome, arthropathy,
strongyloidiasis, cryoglobulinemia, and monoclonal gammopathy among others that produce significant morbidity in infected

Key words: 
Human T lymphotropic virus type 1, infective dermatitis, tropical spastic paraparesis, adult T-cell leukemia/lymphoma.
PDF del articulo

Referencias

  1. Sibon D, Gabet AS, Zandecki M, Pinatel C, Thête J, Delfau-Larue MH, et al. HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from death. J Clin Invest. 2006;116:974-86.
  2. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415-9.
  3. Yamaguchi K. Human T-cell lymphotropic virus type I in Japan. Lancet. 1994;343:213-6.
  4. Blank A, Herrera M, Lourido MA, Rueda R, Blank M. Infective dermatitis in Colombia. Lancet. 1995;346:710.
  5. da Silva JL, Primo JR, de Oliveira M de F, Batista Eda S, MorenoCarvalho O, Farré L, et al. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil. J Clin Virol. 2013;58:482-5.
  6. Chávez M, Domínguez MC, Blank A, Quintana M, Euzuru Y, García F. Reconstrucción de la evolución molecular de la infección actual por el virus linfotrópico humano tipo I en Colombia. Biomédica. 2004;24:20-32.
  7. Mochizuki M, Watanabe T, Yamaguchi K, Tajima K, Yoshimura K, Nakashima  S, et  al.  Uveitis associated with human T lymphotrophic virus type I: Seroepidemiologic, clinical, and virologic studies. J Infect Dis. 1992;166:943-4.
  8. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989;1:441.
  9. Brites  C, Weyll  M, Pedroso  C, Badaro  R. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS. 2002;16:1292-3
  10. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine (Baltimore). 1978;57:527-44.
  11. Maayan S, Wormser GP, Widerhorn J, Sy ER, Kim YH, Ernst JA. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med. 1987;83:945-8.
  12.  Ando Y, Matsumoto Y, Nakano S, Saito K, Kakimoto K, Tanigawa T, et al. Long-term follow up study of vertical HTLV-1 infection in children breast-fed by seropositive mothers. J Infect. 2003;46:177-9.
  13. Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, et al. Patterns of HIV-l and HTLV-I/II in intravenous drug abusers from the middle Atlantic and central regions of the USA. J Infect Dis. 1990;162:347-5.
  14. La Grenade  L, Hanchard  B, Fletcher  V, Cranston  B, Blattner  W. Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet. 1990;336:1345-7.
  15.  Amano M, Setoyama M, Grant A, Kerdel FA. Human T lymphotropic virus 1 (HTLV-1) infection-dermatological implications. Int J Dermatol. 2011;50:915-20.
  16. Maragno L, Casseb J, Fukumori LM, Sotto MN, Duarte AJ, FestaNeto C, Sanches JA. Human T-cell lymphotropic virus type 1 infective dermatitis emerging in adulthood. Int J Dermatol. 2009;48:723-30.
  17. Lee R, Schwartz RA. Human T-lymphotrophic virus type 1-associated infective dermatitis: A comprehensive review. J Am Acad Dermatol. 2011;64:152-60.
  18. La Grenade  L, Manns  A, Fletcher  V, Derm  D, Carberry  C, Hanchard B, et al. Clinical, pathologic, and immunologic features of human T lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol. 1998;134:439-44.
  19. Bittencourt AL, de Oliveira M de F. Cutaneous manifestations associated with HTLV-1 infections. Int J Dermatol. 2010;49:1099-110.
  20. Nascimento MC, Primo J, Bittencourt A, Siqueira I, Oliveira MF. Meyer R, et al. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Clin Exp Immunol. 2009;156:455-62.
  21. Maloney  EM, Yamano  Y, Vanveldhuisen  PC, Sawada  T, Kim  N, Cranston  B, et  al.  Natural history of viral markers in children infected with human T lymphotrophic virus type I in Jamaica. J Infect Dis. 2006;194:552-60.
  22. Goncalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA, Lambertucci  JR. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotrophic virus type-1. Am J Trop Med Hyg. 2003;68:562-5.
  23. Lenzi ME, Cuzzi-Maya T, Oliveira AL, Andrada-Serpa MJ, Araújo AQ. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis. Clin Infect Dis. 2003;36:507-13.
  24. Nobre V, Guedes AC, Proietti FA, Stanciolli E, Martins ML, Serufo JC, et al. Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1). Rev Soc Bras Med Trop. 2005;38:43-52.
  25. Okajima R, Oliveira AC, Smid J, Casseb J Sanches JA Jr. High prevalence of skindisorders among HTLV-1 infected individuals independent of clinical status.PloS Negl Trop Dis.2013;7:e2546
  26. Duval A, Rivet J, Moulonguet I, Cassar O, Agbalika F, Wallach D, et al. Atypical presentation of adult T-cell leukemia/lymphoma due to HTLV-1: Prurigo nodularis lasting twelve years followed by an acute micropapular eruption. Acta Derm Venereol. 2010;90:287-90.
  27. Romanelli LC, Caramelli P, Martins ML, Gonçalves DU, Proietti FA, Ribas JG, et al. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil. AIDS Res Hum Retroviruses. 2013;29:1199-202.
  28. Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Front Microbiol. 2012;3:389.
  29. Gessain A, Mahieux R. Tropical spastic paraparesis and HTLV-1 associated myelopathy: Clinical, epidemiological, virological and therapeutic aspects. Rev Neurol. 2012;168:257-69.
  30. León A, Días R, Gracia F. T-cell lymphoma/leukemia secondary to HTLV-1 in adults. Report of a case. Rev Med Panamá. 1998;23:41-6.
  31. Strutton G. Cutaneous infiltrates–lymphomatous and leukemic. In: Weedon D, editor. Weedon’s Skin Pathology. Third edition. Beijing, China: Churchill-Livingston-Elsevier; 2010. p. 971-1005.
  32. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome) Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70:205.
  33. Johnston RB. Cutaneous lymphomatous and leukemic infiltrates. In: Houston M, commissioning editor. Weedon’s Skin Pathology Essentials. First edition. Dos Hermanas,SEVI, Spain: ChurchillLivingston-Elsevier; 2012. p. 750-69.
  34. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol. 2009;27:453.
  35. Tobinai K. Current management of adult T-cell leukemia/lymphoma. Oncology (Williston Park). 2009;23:1250.
  36. Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, et al. Use of zidovudine and interferon alpha with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma. J Clin Oncol. 2011;29:4696.
  37. Jo T, Ishida T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, et al. Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL). J Clin Oncol. 2013;31:519s.
Syphilis mimicking leprosy reaction type 1
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 74-76
.
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 67-73
.
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 39-55
Preliminary results of the clinical use of electrochemotherapy in patients with skin cancer
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 29-36
Epidemiology of non-melanoma skin cancer in Colombia
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 20-26
Should Scientific Societies participate in the Regulatory Processes of Biological and Biosimilar Drugs?
Rev Asoc Colomb Dermatol. 2014; 22: 1 (Enero-Marzo), 16-17

PATROCINADORES PRINCIPALES

  • MEDIHEALTH
  • SESDERMA
  • MD FARMACIA MAGISTRAL
  • EPIDERMIQUE
  • ISDIN
  • GALDERMA